Suppression of meiosis by inhibitors of m-phase proteins in horse oocytes with low meiotic competence

Zygote

Volumn 10, Issue 1, 2002, Pages 37-45

  Hinrichs, Katrin ^a,b   Love, Charles C ^a   Choi, Young Ho ^a   Varner, Dickson D ^a   Wiggins, C Nicole ^a   Reinoehl, Christina ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

6 DMAP; Butyrolactone; Maturation; MPF; Roscovitine

Indexed keywords

EQUUS CABALLUS;

ADENINE; BUTYROLACTONE I; DIMETHYL SULFOXIDE; DRUG DERIVATIVE; GAMMA BUTYROLACTONE; N(6),N(6) DIMETHYLADENINE; N(6),N(6)-DIMETHYLADENINE; PURINE DERIVATIVE; ROSCOVITINE;

ANIMAL; ARTICLE; CHROMATIN; DRUG EFFECT; HORSE; MEIOSIS; METABOLISM; OOCYTE; OOCYTE DEVELOPMENT; PHYSIOLOGY;

4-BUTYROLACTONE; ADENINE; ANIMALS; CHROMATIN; DIMETHYL SULFOXIDE; HORSES; MEIOSIS; OOCYTES; OOGENESIS; PURINES;

EID: 0036479345     PISSN: 09671994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S096719940200206X     Document Type: Article

References (27)

1. Alm, H. & Hinrichs, K. (1996). Effect of cycloheximide on nuclear maturation of horse oocytes and its relation to initial cumulus morphology. J. Reprod. Fertil. 107, 215-20.
2. cdc2 expression and meiotic competence in growing goat oocytes. Mol. Reprod. Dev. 50, 251-62.
3. cdc2/cyclin B suppresses fertilization-induced calcium oscillations in mouse eggs. Biol. Reprod. 62, 873-8.
4. cdc2 at the end of mouse oocyte growth correlated with acquisition of meiotic competence. Dev. Biol. 174, 335-44.
5. De Vantery, C., Stutz, A., Vassalli, J.D. & Schorderet-Slatkine, S. (1997). Acquisition of meiotic competence in growing mouse oocytes is controlled at both translational and posttranslational levels. Dev. Biol. 187, 43-54.
6. Fulka, J., Liebfried-Rutledge, M.L. & First, N.L. (1991). Effect of 6-dimethylaminopurine on germinal vesicle breakdown of bovine oocytes. Mol. Reprod. Dev. 29, 379-84.
7. Goudet, G., Belin, F., Bezard, J. & Gerard, N. (1998). Maturation-promoting factor (MPF) and mitogen activated protein kinase (MAPK) expression in relation to oocyte competence for in vitro maturation in the mare. Mol. Hum. Reprod. 4, 563-70.
8. Harrouk, W. & Clarke Hugh, J. (1995). Mitogen-activated protein (MAP) kinase during the acquisition of meiotic competence by growing oocytes in the mouse. Mol. Reprod. Dev. 41, 29-36.
9. Hinrichs, K. & Schmidt, A.L. (2000). Meiotic competence in horse oocytes: interactions among chromatin configuration, follicle size, cumulus morphology and season. Biol. Reprod. 62, 1402-8.
10. Hinrichs, K. & Williams, K.A. (1997). Relationships among oocyte-cumulus morphology, follicular atresia and oocyte meiotic competence in the horse. Biol. Reprod. 57, 377-84.
11. Hinrichs, K., Schmidt, A.L. & Selgrath, J.P. (1993a). Atlas of chromatin configurations of germinal vesicle stage and maturing horse oocytes. Equine Vet. J. Suppl. 15, 60-3.
12. Hinrichs, K., Schmidt, A.L., Friedman, P.P., Selgrath, J.P. & Martin, M.G. (1993b). In vitro maturation of horse oocytes: characterization of chromatin configuration using fluorescence microscopy. Biol. Reprod. 48, 363-70.
13. Kastrop, P.M.M., Bevers, M.M., Destree, O.H.J. & Kruip, Th.A.M. (1990). Changes in protein synthesis and phosphorylation patterns during bovine oocyte maturation in vitro. J. Reprod. Fertil. 90: 305-10.
14. Kubelka, M., Rimkevicova, Z., Guerrier, P. & Motlik, J. (1995). Inhibition of protein synthesis affects histone H1 kinase, but not chromosome condensation activity, during the first meiotic division of pig oocytes. Mol. Reprod. Dev. 41, 63-9.
15. Kubelka, M., Motlik, J., Shultz, R.M. & Pavlok, A. (2000). Butyrolactone I reversibly inhibits meiotic maturation of bovine oocytes, without influencing chromosome condensation activity. Biol. Reprod. 62, 292-302.
16. Levesque, J.T. & Sirard, M.A. (1995). Effects of different kinases and phosphatases on nuclear and cytoplasmic maturation of bovine oocytes. Mol. Reprod. Dev. 42, 114-21.
17. Levesque, J.T. & Sirard, M.A. (1996). Resumption of meiosis is initiated by the accumulation of cyclin B in bovine oocytes. Biol. Reprod. 55, 1427-36.
18. Lonergan, P., Khatir, H., Carolan, C. & Mermillod, P. (1997). Bovine blastocyst production in vitro after inhibition of oocyte meiotic resumption for 24 h. J. Reprod. Fertil. 109, 355-65.
19. Love, C.C., Love, L.B., Varner, D.D. & Hinrichs, K. (2002). Effect of holding at room temperature after recovery on initial chromatin configuration and in vitro maturation rate of equine oocytes. Theriogenology, in press.
20. Mermillod, P., Tomanek, M., Marchai, R. & Meijer, L. (2000). High developmental competence of cattle oocytes maintained at the germinal vesicle stage for 24 h in culture by specific inhibition of MPF kinase activity. Mol. Reprod. Dev. 55, 89-95.
21. Moos, J., Visconti, P.E., Moore, G.D., Schultz, R.M. & Kopf, G.S. (1995). Potential role of mitogen-activated protein kinase in pronuclear envelope assembly and disassembly following fertilization of mouse eggs. Biol. Reprod. 53, 692-9.
22. Motlik, J., Pavlok, A., Kubelka, M., Kalous, J. & Klab, P. (1998). Interplay between cdc2 kinase and MAP kinase pathway during maturation of mammalian oocytes. Theriogenology 49, 461-9.
23. cdc2 and cyclin B during meiotic maturation of porcine oocytes. Dev. Biol. 168, 627-34.
24. Rime, H., Neant, I., Guerrier, P. & Ozon, R. (1989). 6-Dimethylaminopurine (6-DMAP), a reversible inhibitor of the transition to metaphase during the first meiotic cell division of the mouse oocyte. Dev. Biol. 133, 169-79.
25. Saeki, K., Nagao, Y., Kishi, M. & Nagai, M. (1997). Developmental capacity of bovine oocytes following inhibition of meiotic resumption by cycloheximide or 6-dimethylaminopurine. Theriogenology 48, 1161-72.
26. Sirard, M.A. & Coenen, K. (1995). Effects of inhibition of meiotic resumption upon the subsequent development of bovine oocytes in vitro. J. Reprod. Dev. 41, 255-62.
27. Tatemoto, H. & Horiuchi, T. (1995). Requirement for protein synthesis during the onset of meiosis in bovine oocytes and its involvement in the autocatalytic amplification of maturation-promoting factor. Mol. Reprod. Dev. 41, 47-53.